Iida Ayako, Yoshidome Hiroyuki, Kaneko Takaaki, Shimizu Kimio, Mishima Takashi, Muto Takaaki, Miyazaki Masaru
Department of Surgery, Ibaraki Kensei General Hospital, and Department of General Surgery, Chiba University Graduate School of Medicine.
Gan To Kagaku Ryoho. 2009 Nov;36(12):2190-2.
A 60-year-old man was admitted to our institution having a descending colon cancer with synchronous liver metastases. Tumor marker levels were remarkably elevated and the liver metastases were multiple and located at both right lobe and segment 4. Due to lack of the remnant liver volume, left hemicolectomy and intraoperative right portal vein branch embolization were performed as a primary operation. Three weeks after the operation, he started to undergo systemic chemotherapy by mFOLFOX6. After 8 courses of the treatment, grade 3 neurotoxicity appeared, and we changed the regimen to FOLFIRI. During a total of 18 courses of the chemotherapy, the periodic CT scans revealed the liver metastases to be PR or SD, and no other metastatic lesion was detected. After the rest of chemotherapy for 7 weeks, extended right hepatectomy was performed. He had an uneventful postoperative course and the tumor marker levels immediately returned to normal levels. He has been in good health without a recurrence for 10 months after hepatectomy. The combination of portal vein embolization and systemic chemotherapy may contribute to improve respectability of synchronous multiple and bilobar colorectal liver metastases.
一名60岁男性因降结肠癌伴同时性肝转移入住我院。肿瘤标志物水平显著升高,肝转移灶为多发,位于右叶和4段。由于残余肝体积不足,一期手术行左半结肠切除术及术中右门静脉分支栓塞术。术后3周,他开始接受mFOLFOX6全身化疗。治疗8个疗程后,出现3级神经毒性,我们将治疗方案改为FOLFIRI。在总共18个疗程的化疗期间,定期CT扫描显示肝转移灶为部分缓解(PR)或疾病稳定(SD),未检测到其他转移病灶。在其余7周的化疗后,行扩大右肝切除术。他术后恢复顺利,肿瘤标志物水平立即恢复正常。肝切除术后10个月,他一直健康,无复发。门静脉栓塞和全身化疗相结合可能有助于提高同时性多发和双叶结直肠癌肝转移的可切除性。